. [=] . . . . . MRC 12 3 83 , , . , . 1921 70 82 , 1936 79 92 3 . . … [+278 chars]
. [=] (PTH, Posttraumatic Headache) . , , ()· . (CBT) . (UT Health San Antonio) 9·11 193( 39.7, 87% ) , . 1 80% , 20% . (MRI) . , , , , , . . , (PTH) (PTSD) . 40% . . (CBT), (CPT), (TPU) 6… [+404 chars]
# (43). . 2‘’ . 2012~2021, 102.6. 13,7434038.8%(5,330), 3036.7%(5,048)30~4075.5%. (). , . , , . . . . . , . 130~40%. 12.8%. . “, ”“”.
7 6 A A , . (23) 7 6 . . , A . A 7 . A . 10 . , , . . 4 1 A . , , , , . A . A . , . A . 5 A . 19 . , . A , H1N1, H5N1, H7N9 . , . , 39~40 . , , , , , ... . , .
. "" . , "" . "" . "", ... A 10 . . “ ” “ ” . . 41 45 15 6 . , 40 20 2 . ? 36.5 2~3 . , . , D . .
2020 630 . 2050 1000 . 2030 10% 200 . , . , . 2000 45~65 1000 . 1 (57.7%) . (51.9%), (42.4%), (39.6%), (35.4%) . ? 24.1% . 43.6%, 32.3%. . . 36.3% , 31% . 40.1% . . . 2000 , 5 14% . 2… [+75 chars]
[·= ] NIP . ‘4’ SK 19 NIP . SK ‘’ . SK ‘’ . 2021~2022 7200 ·. ‘’ FDA . 1 4000 . . 2012 FDA . , . 10 14 ‘NEJM’ 2~18 , . FDA 6 . . MF59® 65 . " 1 4000 " .
. , B . . 488 , B· . B· 1 ( ) . · . , B(B1·B2·B3·B5·B6·B9·B12) . , . B9, B12 . B9 57 755, 196 774. B12 0.62 732, 5.93 780. B12 , . B9 , . , . B · . .
. [=] (PTH, Posttraumatic Headache) . , , ()· . (CBT) . (UT Health San Antonio) 9·11 193( 39.7, 87% ) , . 1 80% , 20% . (MRI) . , , , , , . . , (PTH) (PTSD) . 40% . . (CBT), (CPT), (TPU) 6… [+404 chars]
[ / ] 5 JAK() ‘‘(Xeljanz, : ·tofacitinib) 4 2 . ‘’() 5mg () . ‘‘ , , . ‘’ ‘’() 5mg . ‘’() (, ) . A( 8 ) 12 , . ‘’(+ +30%) () . , , , , , , , , . ‘’(+390) 5/1000mg () . (CHD) 20mg … [+169 chars]
. [=] 25 1 (·) . 2 . , . . (Mex3a) . (Mex3a) ( ) . () . , . (Eduard Batlle) , . ( ) . (IRB Barcelona) (ICREA) . ( ) (Organoid, ) . . 3 . (transcriptomic analysis) . (Mex3a marks drug-toler… [+165 chars]
[ / ] 6 . . . . . “ ” . 19 , . . . . . . . , , , . , , , , . . . , . , , . . , , . . . . , . . . , , . , , . “ ” . ·· ( ) “ , ” “ ” . . . . ,… [+24 chars]
